RLMD
NASDAQ · Pharmaceuticals
Relmada Therapeutics Inc
$7.32
-0.11 (-1.48%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+410.5% upside
Low Target
$22.23
Average Target
$37.37
High Target
$43.38
Current Price
$7.32
Current
$7.32
$7.32
Target
$37.37
$37.37
$22.23
$37.37 avg
$43.38
Scenario Analysis
Bear Case
$22.23
203.7%
Low target
Base Case
$37.37
+410.5%
Avg target
Bull Case
$43.38
+492.6%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$8.00
-8.5% from high
52-Week Low
$0.32
+2,164.2% from low
Target vs 52W High
$37.37
+367.1% vs high
Next Earnings Report
May 12, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.20
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals